Positive predictive value of a point-of-care testing strategy on first-draw specimens for the emergency department-based detection of acute coronary syndromes

Archives of Pathology and Laboratory Medicine

Volumn 126, Issue 12, 2002, Pages 1487-1493

  Kratz, Alexander ^a   Januzzi, James L ^a   Lewandrowski, Kent B ^a   Lee Lewandrowski, Elizabeth ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; MYOGLOBIN; TROPONIN I; TROPONIN T;

ANAMNESIS; ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; EMERGENCY WARD; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LABORATORY DIAGNOSIS; PHYSICAL EXAMINATION; QUALITATIVE DIAGNOSIS; THORAX PAIN;

CHEST PAIN; CREATINE KINASE; CREATINE KINASE, MB FORM; EMERGENCIES; HUMANS; ISOENZYMES; MYOCARDIAL ISCHEMIA; MYOGLOBIN; POINT-OF-CARE SYSTEMS; TROPONIN T;

EID: 0037002639     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hlatky MA. Evaluation of chest pain in the emergency department. N Engl J Med. 1997;337:1687-1689.
2. Levitt MA, Promes SB, Bullock S, et al. Combined cardiac marker approach with adjunct two-dimensional echocardiography to diagnose acute myocardial infarction in the emergency department. Ann Emerg Med. 1996;27:1-7.
3. Jernberg T, Lindahl B, Wallentin L. The combination of a continuous 12-lead ECG and troponin T. Eur Heart J. 2000;21:1464-1472.
4. Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery disease. Clin Chem. 1999;45:1104-1121.
5. Brogan GX, Friedman S, McCuskey C, et al. Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department. Ann Emerg Med. 1994;24:665-671.
6. Luescher MS, Ravkilde J, Thygesen K. Clinical application of two novel rapid bedside tests for the detection of cardiac troponin T and creatine kinase-MB mass/ myoglobin in whole blood in acute myocardial infarction. Cardiology. 1998;89:222-228.
7. Heeschen C, Hamm CW, Goldman B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet. 1999;354:1757-1762.
8. Hamm CW, Heeschen C, Goldman B, et al. Benefit of Abciximab in patients with refractory unstable angina in relation to serum troponin I levels. N Engl J Med. 1999;340:1623-1629.
9. Januzzi JL, Chae CU, Sabatine MS, Jang IK. Elevation in serum troponin I predicts the benefit of tirofiban. J Thromb Thrombolysis. 2001;11:211-215.
10. Newby LK, Ohman EM, Christenson RH, et al. Benefit of glycoprotein IIb/ IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: the paragon-B troponin T substudy. Circulation. 2001;103:2891-2896.
11. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularization during InStability in Coronary artery disease (FRISC II) investigators. Lancet. 1999;354:708-715.
12. Cannon CP, Weintraub WS, Demonopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344: 1879-1887.
13. Apple FS, Christenson RH, Valdes R, et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. Clin Chem. 1999;45:199-205.
14. Sylven C, Lindahl S, Hellkvist K, Nyquist O, Rasmanis G. Excellent reliability of nurse-based bedside diagnosis of acute myocardial infarction by rapid dry-strip creatine kinase MB, myoglobin, and troponin T. Am Heart J. 1998;135:677-683.
15. Collinson PO. Testing for cardiac markers at the point of care. Clin Lab Med. 2001;21:351-363.
16. Bakker AJ, Koelemay MJW, Gorgels JPMC, et al. Failure of new biochemical markers to exclude acute myocardial infarction at admission. Lancet. 1993;34:1220-1222.
17. Donaldson A, Cove-Smith R. Cardiac troponin levels in patients with impaired renal function. Hosp Med. 2001;62:86-89.
18. Jaffe AS, Ravkilde J, Roberts R, et al. It's time for a change to a troponin standard. Circulation. 2000;102:1216-1220.
19. Meyer T, Binder L, Hruska N, Luthe H, Buchwald A. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol. 2000;36:1632-1636.
20. Apple FS, Jaffe AS. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study [correspondence]. Circulation. 2001;104:125.
21. Brogan GX, Bock JL. Cardiac marker point-of-care testing in the emergency department and cardiac care unit. Clin Chem. 1998;44:1865-1869.
22. Wright SA, Sawyer DB, Sacks DB, Chyu S, Goldhaber SZ. Elevation of troponin I levels in patients without evidence of myocardial injury. JAMA. 1997;278:2144.
23. Azzazy HME, Alonsozana GL, Jockle GA, Christenson RH. Elevated cardiac troponin I with no myocardial necrosis in a patient with metastatic liver tumor. Clin Chem. 1997;43:S138.
24. Newby LK, Storrow AB, Gibler WB, et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation. 2001;103: 1832-1837.
25. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. Circulation. 1994;89:1545-1556.
26. Ng SM, Krishnaswamy P, Morrisey R, Clopton P, Fitzgerald R, Maisel AS. Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. Am J Cardiol. 2001;87:994-999.
27. Ng SM, Krishnaswamy P, Morrisey R, Clopton P, Fitzgerald R, Maisel AS. Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol. 2001;88:611-617.
28. Maisel AS, Templin K, Love M, Clopton P. A prospective study of an algorithm using cardiac troponin I and myoglobin as adjuncts in the diagnosis of acute myocardial infarction and intermediate coronary syndromes in a veteran's hospital. Clin Cardiol. 2000;23:915-920.
29. McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation. 2001;104:1483-1488.
30. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
31. Apple FS, Wu AHB. Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem. 2001;47:377-379.